Immunogenicity and efficiency of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis: results of a 5-year follow up study

Immunogenicity and efficiency of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis: results of a 5-year follow up study

Objective: to study the efficacy, immunogenicity, and safety of a 23-valent pneumococcal polysaccharide vaccine (PPSV-23) in patients with rheumatoid arthritis (RA) receiving disease-modifying antirheumatic drugs (DMARDs) and biologic agents (BAs) during a 5-year follow-up.Patients and methods. The...

Full description

Bibliographic Details
Main Authors: D. V. Bukhanova, M. S. Sergeeva, B. S. Belov, G. M. Tarasova, M. V. Cherkasova, Yu. A. Muraviev, G. V. Lukina, N. V. Demidova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2018-12-01
Series:Современная ревматология
Subjects:
rheumatoid arthritis
pneumonia
vaccination
pneumococcal vaccine
Online Access:https://mrj.ima-press.net/mrj/article/view/866

Internet

https://mrj.ima-press.net/mrj/article/view/866

Similar Items